Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.
about
Calcium phosphate nanoparticles-based systems for siRNA deliveryLipid-based vectors for siRNA deliveryBiodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery.Gene delivery from supercharged coiled-coil protein and cationic lipid hybrid complex.Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer.Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid TumorsNanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.Structure and stability of the complex formed by oligonucleotides.Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.More effective nanomedicines through particle designIn vitro evaluation of optimized liposomes for delivery of small interfering RNA.Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.Effect of surface properties on liposomal siRNA delivery.Delivery of intracellular-acting biologics in pro-apoptotic therapies.Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.NANOSCALE SELF-ASSEMBLY FOR DELIVERY OF THERAPEUTICS AND IMAGING AGENTS.Synthesis of bisethylnorspermine lipid prodrug as gene delivery vector targeting polyamine metabolism in breast cancer.Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery.Nanoparticles evading the reticuloendothelial system: role of the supported bilayer.Oligonucleotide delivery in cancer therapy.Recent advances in delivery of drug-nucleic acid combinations for cancer treatmentDelivery of RNAi therapeutics: work in progress.Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.Delivering the promise of small ncRNA therapeutics.Star-shaped tetraspermine enhances cellular uptake and cytotoxicity of T-oligo in prostate cancer cells.Recent advances in siRNA delivery.Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment.Targeting Nanocarriers with Anisamide: Fact or Artifact?Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy.Advances in Lipid Nanoparticles for siRNA Delivery.Self-Assembled Lipoplexes of Short Interfering RNA (siRNA) Using Spermine-Based Fatty Acid Amide Guanidines: Effect on Gene Silencing Efficiency.Nanoplatforms for magnetic resonance imaging of cancer.Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo.Efficient Fusion of Liposomes by Nucleobase Quadruple-Anchored DNA.
P2860
Q26744039-BDF8E410-426C-4D6E-A315-EEBE14FB9DF5Q28828356-52896B6E-5E1B-40BC-A4CA-64BC48D2106CQ33708084-E7FB68F0-8051-40D5-837B-8B4100C75795Q33904910-4C0D1051-9B3E-4CDF-B029-D7FB86CF16CDQ33991008-22893E89-7750-41C7-B0B4-2DD6468FB2A2Q34165321-DE96958F-E7DF-4BB0-A271-459C16A33E97Q34209735-5E110A38-36DF-464A-8A90-A1E2C02A9975Q34239895-406C9608-25AA-4FE0-A5AD-4025459DE13FQ34622662-603C865C-BA82-4321-A044-EAF70E0B9B3CQ35106115-AB3606D7-9A07-4CED-AB7E-C5E1ECECC9D7Q35140847-7D40C4EA-4E6A-4FBF-8B28-1C70EB7B0796Q35167546-D496C89F-62E4-4F33-A28E-090C00D95DD3Q36421379-26DDC8F7-4863-405C-811F-C9F20FD0D8E8Q36588920-49BD3D19-0AFE-4A16-93EB-35B85A8ADDE1Q36673747-2108765D-CAEB-4C0F-A2AE-8C921BF23854Q37201160-F026B8CA-3C5C-442D-904E-4E570A4ED0BBQ37243049-726A74F9-23EE-42E1-A45B-2D517BB352A3Q37251480-75D809DF-4B83-4658-96B1-6EEA44183F31Q37376443-B306A742-7892-4192-95E4-3E51782FE430Q37803214-CBD8693B-A37D-454A-9F4F-5BDFCDA8E235Q38102522-93E7C928-AEB0-4410-A28C-ED89843C0FCFQ38160246-58A0B932-C7F9-464B-834F-475A77B079F3Q38183852-F75C85F6-B495-4681-B165-DEBDD51ED2E6Q38226666-7EB4A936-A6D7-4FB4-A018-3173CE7A2E63Q38305253-366D15FB-C2ED-4AF6-AFA7-FDEE95F67EB8Q38648525-13E0EF62-6336-4780-ABC4-7A4F72760FA2Q38665199-662201C9-8FF8-47FC-B468-BB2979D3B358Q39019352-7816B501-DBBA-438D-B555-403E7FA483C9Q39196485-3037792E-DEC6-43CA-932B-DA00F92014CDQ39752739-C20CD14A-BBE3-45F9-94B8-D5A70F53AE47Q41786279-9F878DB0-82B7-46C5-A581-44FD66F770FDQ41840312-24CFBF46-062A-4B81-9D6D-779F208F9484Q42083011-4B04E4E1-93D0-448D-B241-5A434173495BQ47729841-E1C60ABB-1CFA-4D42-9414-378B67F0AA63Q48131865-62E61511-7E80-4E15-893B-D9A39EE82E98
P2860
Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel cationic lipid that deli ...... c effect in lung cancer cells.
@en
Novel cationic lipid that deli ...... c effect in lung cancer cells.
@nl
type
label
Novel cationic lipid that deli ...... c effect in lung cancer cells.
@en
Novel cationic lipid that deli ...... c effect in lung cancer cells.
@nl
prefLabel
Novel cationic lipid that deli ...... c effect in lung cancer cells.
@en
Novel cationic lipid that deli ...... c effect in lung cancer cells.
@nl
P2093
P2860
P356
P1476
Novel cationic lipid that deli ...... c effect in lung cancer cells.
@en
P2093
Joyeeta Sen
Leaf Huang
Surendar Reddy Bathula
P2860
P304
P356
10.1021/MP800136V
P407
P577
2009-05-01T00:00:00Z